BidaskClub downgraded shares of AngioDynamics (NASDAQ:ANGO) from a hold rating to a sell rating in a research note released on Thursday.
A number of other research analysts have also recently issued reports on the stock. Zacks Investment Research cut shares of AngioDynamics from a buy rating to a hold rating in a report on Friday, January 26th. Craig Hallum cut shares of AngioDynamics from a buy rating to a hold rating in a report on Friday, January 5th. Finally, TheStreet cut shares of AngioDynamics from a b- rating to a c rating in a report on Tuesday, January 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of $18.60.
Shares of AngioDynamics (NASDAQ:ANGO) opened at $16.54 on Thursday. AngioDynamics has a 1 year low of $14.80 and a 1 year high of $18.85. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.65 and a current ratio of 2.56. The company has a market cap of $607.76, a P/E ratio of -78.76, a PEG ratio of 1.53 and a beta of 0.98.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Segall Bryant & Hamill LLC acquired a new position in AngioDynamics during the fourth quarter valued at approximately $4,495,000. MetLife Investment Advisors LLC acquired a new position in AngioDynamics during the fourth quarter valued at approximately $297,000. Municipal Employees Retirement System of Michigan grew its holdings in AngioDynamics by 21.0% during the fourth quarter. Municipal Employees Retirement System of Michigan now owns 105,210 shares of the medical instruments supplier’s stock valued at $1,750,000 after purchasing an additional 18,230 shares during the period. Stone Ridge Asset Management LLC acquired a new position in AngioDynamics during the fourth quarter valued at approximately $652,000. Finally, Guggenheim Capital LLC acquired a new position in AngioDynamics during the fourth quarter valued at approximately $559,000. Hedge funds and other institutional investors own 94.55% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “AngioDynamics (ANGO) Lowered to “Sell” at BidaskClub” was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.com-unik.info/2018/02/19/angiodynamics-ango-lowered-to-sell-at-bidaskclub-2.html.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.